Second Primary Malignancies after Commercial CAR T Cell Therapy: Analysis of FDA Adverse Events Reporting System (FAERS)
Blood（2024）
Key words
CAR T,Safety,Second primary neoplasm,T-cell Lymphoma,Lymphoma,Leukemia,Myeloma,Myeloid neoplasm,Myelodysplastic syndrome
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined